Generex Biotechnology Co. (OTCMKTS:GNBT – Get Free Report)’s share price crossed above its 200-day moving average during trading on Monday . The stock has a 200-day moving average of $0.00 and traded as high as $0.00. Generex Biotechnology shares last traded at $0.00, with a volume of 0 shares changing hands.
Generex Biotechnology Price Performance
Generex Biotechnology Company Profile
Generex Biotechnology Corporation, through its subsidiaries, engages in the administration of formulations of large molecule drugs to the oral cavity using a hand-held aerosol applicator in Canada and the United States. It offers Generex Oral-lyn, an oral insulin product. The company is also developing AE37, a synthetic peptide vaccine, which has completed Phase IIb clinical trial to stimulate a potent and specific immune response against tumors expressing the HER-2/neu oncogene in patients with breast cancer and prostate cancer.
Read More
- Five stocks we like better than Generex Biotechnology
- Dividend King Proctor & Gamble Is A Buy On Post-Earnings Weakness
- Inflation Risk Rising, Key Trades Investors Are Making Now
- Using the MarketBeat Stock Split Calculator
- 3 Oil Stocks to Watch Before Earnings Come Out
- Find and Profitably Trade Stocks at 52-Week Lows
- Is American Express Stock’s Sell-the-News Reaction a Buying Opp?
Receive News & Ratings for Generex Biotechnology Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Generex Biotechnology and related companies with MarketBeat.com's FREE daily email newsletter.
